VirginiaMedication, drug, and vaccine ingredient labeling; Board of Pharmacy, et al., to study.
What it does
Board of Pharmacy; work group to study medication, drug, and vaccine ingredient labeling; report. Directs the Board of Pharmacy to convene a work group to study medication, drug, and vaccine ingredient labeling. The bill directs the work group to review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (i) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (ii) accompanying informational inserts are readily available to consumers at a pharmacy upon request.
More detail
The bill also directs the work group to study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The bill requires the work group to report its findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by December 1, 2026.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Feb 18Left in Committee RulesLatest
- Jan 23Subcommittee recommends laying on the table (5-Y 0-N)
- Vote recorded Subcommittee recommends laying on the table. Result: pass.Lower
- Jan 23House subcommittee offered
- Jan 22Assigned HRUL sub: Studies SubcommitteeMinor
- Jan 13Referred to Committee on RulesMinor
- Jan 13Prefiled and ordered printed; Offered 01-14-2026 26103422DIntroduced